3,273
Views
8
CrossRef citations to date
0
Altmetric
Research paper

Network pharmacology and experimental validation to explore the molecular mechanisms of Bushen Huoxue for the treatment of premature ovarian insufficiency

, , , , &
Pages 10345-10362 | Received 19 Aug 2021, Accepted 16 Oct 2021, Published online: 02 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Shaoqing Chen, Yifang Gao, Haichao Liu, Jin Jing, Zhengyu Yang, Haoming Zhu, Bairui Chen, Yu Wang, Ting Zhang, Shizhong Wang & Jianping Lin. (2023) Chinese medicinal herbs for reducing endocrine therapy-induced side effects in patients with hormone receptor‐positive breast cancer: a systematic review and meta-analysis. Pharmaceutical Biology 61:1, pages 722-736.
Read now
Xinnan Ma, Xin Zhang, Yuanhang Kong, Bo Su, Leilei Wu, Daqian Liu & Xintao Wang. (2022) Therapeutic effects of Panax notoginseng saponins in rheumatoid arthritis: network pharmacology and experimental validation. Bioengineered 13:6, pages 14438-14449.
Read now
Yuexin Yu, Qian Zhang, Kaixuan Sun, Yinling Xiu, Xiliang Wang, Kaiyue Wang & Li Yan. (2022) Long non-coding RNA BBOX1 antisense RNA 1 increases the apoptosis of granulosa cells in premature ovarian failure by sponging miR-146b. Bioengineered 13:3, pages 6092-6099.
Read now
Lili Zhang, Bin Mao, Xiaodong Zhao, Yue Yuan, Wei Wang & Shaohua Lin. (2022) Translation regulatory long non-coding RNA 1 (TRERNA1) sponges microRNA-23a to suppress granulosa cell apoptosis in premature ovarian failure. Bioengineered 13:2, pages 2173-2180.
Read now

Articles from other publishers (4)

Xiaofeng Liu, Luying Jiang, Li Li, Fuping Lu & Fufeng Liu. (2023) Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions. Heliyon 9:1, pages e12890.
Crossref
Guoliang Yin, Hongyi Liang, Wenxiu Sun, Shizhao Zhang, Yanan Feng, Pengpeng Liang, Suwen Chen, Xiangyi Liu, Wenchao Pan & Fengxia Zhang. (2022) Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo. Frontiers in Pharmacology 13.
Crossref
Xin Tan, Yan-Ping Du, Qian Luo, Xue-Bing Zhan, Yun-Shu Kuang, Xiao Liang, Yun Zhang, Lin Wang, Bing Chen & Ming Wen. (2022) Network Pharmacology and Molecular Docking Analysis of the Mechanism Underlying Yikunyin’s Therapeutic Effect on Menopausal Syndrome. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-14.
Crossref
Xue Li, Dongyue Zhou, Di Yang, Yunhua Fu, Xingyu Tao, Xuan Hu, Yulin Dai & Hao Yue. (2022) Isoquercitrin Attenuates Osteogenic Injury in MC3T3 Osteoblastic Cells and the Zebrafish Model via the Keap1-Nrf2-ARE Pathway. Molecules 27:11, pages 3459.
Crossref